Retrograde Approach for Percutaneous Ventricular Septal Defect Closure: Is It Really Better Than Antegrade?
Abstract
Introduction. This study was designed to compare the antegrade and retrograde approaches for percutaneous ventricular septal defect (VSD) closure, in light of ongoing debates regarding the advantages and disadvantages of each approach. To the best of our knowledge, there is currently no published literature comparing the immediate and longterm outcomes of these two techniques for transcatheter VSD closure.
Materials and methods. From August 2012 to January 2025, 254 patients underwent percutaneous ventricular septal defect closure using various devices. Of these, 103 patients were treated with the antegrade approach (Group 1), and 151 patients with the retrograde approach (Group 2). The mean follow-up period was 59.5 ± 35.5 months in Group 1 and 54.5 ± 21.4 months in Group 2 (p = 0.45).
Results. The procedure was successful in 97 patients (94.17%) in Group 1 and in 151 patients (100%) in Group 2. The number of major complications was approximately equal in both groups (p = 0.49). Two patients in Group 1 were referred to surgery due to the new onset of significant aortic or tricuspid insufficiency. One patient in Group 2 developed complete atrioventricular (A-V) block complicated by dilated cardiomyopathy two years after perimembranous ventricular septal defect closure. Four patients (3.88%) in Group 1 experienced hemodynamic collapse due to valve compromise from the arterio-venous loop, compared to zero patients in Group 2 (p = 0.014). The number of minor complications was similar in both groups (16 patients, 15.53%, in Group 1 vs 17 patients, 11.25%, in Group 2; p = 0.31).
The mean fluoroscopy time and mean procedure time were significantly lower in Group 2 compared to Group 1 (31.56 ± 23.7 vs 17.6 ± 16.2 minutes, p = 0.001; and 55.8 ± 32.9 vs 117.5 ± 57.8 minutes, p < 0.001).
Conclusions. The retrograde approach appeared to be technically simpler, requiring only one vessel puncture, and had zero complications associated with the creation of a transcardiac loop. The number of perioperative, medium-term, and long-term complications was similar in both groups. However, the antegrade approach can still be applied in patients with low weight and large defects, as well as in cases with a deficient rim to the aortic valve or defects requiring the implantation of asymmetric devices.
References
2. Carminaty M et all. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J. 2007;28:2361-2368. DOI: 10.1093/eurheartj/ehm314
3. Alejandro Rasines Rodrigues et all. Retrograde closure of perimembranous ventricular septal defects. A paradigm shift. Interventional cardiol Es. 2022;5(1). https://dx.doi.org/10.24875/recic.m22000341
4. Kalyanasundaram Muthusamy. Retrograde closure of perimembranous ventricular septal defect using muscular ventricular septal occluder: a single center experience of a novel technique. Pediatr cardiol. 2015 Jan;36(1):106-10. DOI: 10.1007/s00246-014-0971-x
5. Nihat Pekel et all. Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial approach. Anatol J Cardiol. 2017 Feb 21;17(6):461-468. doi: 10.14744/AnatolJCardiol.2017.7507
6. Raymond N Haddad et all. Device Closure of perimembranous Ventricular Septal defect: Choosing Between Amplatzer occlude. Front Pediatr. 2019 Aug 16;7:300. DOI: 10.3389/fped.2019.00300
7. Hala Elmarsafawy et all. Long-term outcomes of percutaneous closure of ventricular septal defects in children using different devices: A single center experience from Egypt. BMC Pediatrics 2023;381. https://doi.org/10.1186/s12887-023-04194-9
8. Margaret Louise Morrison and Colin J. McMahon. Congenital heart disease in down syndrome. In book: Advances in Research on Down Syndrome, 2018. DOI:10.5772/intechopen.71060
9. Victoria Delgado et all. 2023 ESC Guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC). European Heart Journal. 2023;14 October 44, 39: 3948-4042. doi: 10.1093/eurheartj/ehad193.
10. Diandong Jiang et all. Transcatheter device closure of perimembranous and intracristal ventricular septal defects in children: medium- and long-term results. J of AHA. 2021;10(11). https://doi.org/10.1161/JAHA.120.02041
11. Maria Alvares-Fuente et all. Percutaneous closure of ventricular septal defect with the KONAR-MF device. REC Interv Cardiol. 2022;4:181-185. DOI: https://doi.org/10.24875/RECICE.M22000277
12. Masood Sadig et all. Percutaneous closure of ventricular septal defect using LifeTechTM Konar-MF VSD occluder: initial and short-term multi-institutional results. Cardiology in the young. 2022 May;32(5): 755-761. doi:10.1017/S1047951121002985
13. Kozlik-Feldman et all. Long-term outcome of perimembranous VSD closure using the Nit-occlud le VSD coil. Clin res Cardiol. 2021;110:382-390. DOI: 10.1007/s00392-020-01750-6
14. Diandong Jiang et all. Predictors and long-term outcomes of heart block after transcatheter device closure of perimembranous ventricular septal defect. Front. Cardiovasc. Med. 2022 October;9. DOI: 10.3389/fcvm.2022.1041852
15. Yang R. et all. Risk factors and outcomes of post-procedure heart blocks after transcatheter device closure of perimembranous ventricular septal defect. Jacc Cardiovasc Interv. 2012;5:422-427. DOI: 10.1016/j.jcin.2012.01.015
16. Buttera G, Carminati M, Chessa M. et all. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007;50:1189-1195. DOI: 10.1016/j.jacc.2007.03.068
17. Bai J et all. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: a single center experience on 1046 cases. Heart Rhythm. 2015;12:2132-2140. DOI: 10.1016/j.hrthm.2015.05.014
18. Qiuman Li et all. Progression of aortic regurgitation following transcatheter closure of intracristal ventricular septal defects in children: a mid- to long-term follow-up study. Front cardiovasc Med. 2023 May 3;10. https://doi.org/10.3389/fcvm.2023.1190013
19. Raymond N. Haddad. Word of causion: severe aortic valve injury linked to retrograde closure of perimembranous ventricular septal defects. Journal of cardiac surgery 2022;37(6). DOI:10.1111/jocs.16441
20. Mohammadreza Edraki et all. Mitral and aortic valve regurgitation following surgical and transcatheter perimembranous ventricular septal defect closure in children and adolescents: midterm outcomes. BMC Cardiovascular Disorders. 2022;22(1):315. https://doi.org/10.1186/s12872-022-02757-9
